UNSPSC 51162320: Ammonium/antimony/chlorpheniramine/potassium guaiacolsulfonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162320 Ammonium/antimony/chlorpheniramine/potassium guaiacolsulfonate is a Commodity code that shows minimal alignment between its nominal chemical-compound scope and actual state and local procurement activity under the code. Recent solicitations tagged to this code involve naloxone and drug deactivation systems for emergency response, as well as generic multi-source pharmaceuticals and over-the-counter products for cooperative purchasing arrangements — neither of which relates to the code's stated chemical components. The issuing bodies include county health departments and multistate cooperative purchasing alliances serving state and local facilities, reflecting a mix of direct health procurement and cooperative purchasing vehicles.

Activity appears sparse and geographically dispersed. Seminole County, Florida posted an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually (response deadline July 26, 2023), while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP posted January 20, 2026 for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities including Oregon (response deadline March 26, 2026). The code shows little relevant recent activity mapped to its intended commodity scope; buyers pursuing opportunities in pharmaceutical or emergency-response products should verify actual UNSPSC coding with issuing bodies before bid preparation, as tagging accuracy appears inconsistent.